Defective oxidation of drugs: pharmacokinetic and therapeutic implications.
D000654:Amobarbital / Q000378:metabolism; D001682:Biological Availability; D003647:Debrisoquin / Q000378:metabolism; D004358:Drug Therapy; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D007700:Kinetics; D008967:Molecular Biology; D010084:Oxidation-Reduction; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D010672:Phenytoin / Q000378:metabolism; D013034:Sparteine / Q000378:metabolism; D013237:Stereoisomerism; D014044:Tolbutamide / Q000378:metabolism
D004364:Pharmaceutical Preparations; D013034:Sparteine; D010672:Phenytoin; D014044:Tolbutamide; D000654:Amobarbital; D003647:Debrisoquin